Literature DB >> 26372273

A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity.

Giovanni Guaraldi1, Thomas D Brothers, Stefano Zona, Chiara Stentarelli, Federica Carli, Andrea Malagoli, Antonella Santoro, Marianna Menozzi, Chiara Mussi, Cristina Mussini, Susan Kirkland, Julian Falutz, Kenneth Rockwood.   

Abstract

OBJECTIVES: Aging with HIV is associated with multisystem vulnerability that might be well characterized by frailty. We sought to construct a frailty index based on health deficit accumulation in a large HIV clinical cohort and evaluate its validity including the ability to predict mortality and incident multimorbidity. DESIGN AND METHODS: This is an analysis of data from the prospective Modena HIV Metabolic Clinic cohort, 2004-2014. Routine health variables were screened for potential inclusion in a frailty index. Content, construct, and criterion validity of the frailty index were assessed. Multivariable regression models were built to investigate the ability of the frailty index to predict survival and incident multimorbidity (at least two chronic disease diagnoses) after adjusting for known HIV-related and behavioral factors.
RESULTS: Two thousand, seven hundred and twenty participants (mean age 46 ± 8; 32% women) provided 9784 study visits; 37 non-HIV-related variables were included in a frailty index. The frailty index exhibited expected characteristics and met validation criteria. Predictors of survival were frailty index (0.1 increment, adjusted hazard ratio 1.63, 95% confidence interval 1.05-2.52), current CD4 cell count (0.48, 0.32-0.72), and injection drug use (2.51, 1.16-5.44). Predictors of incident multimorbidity were frailty index (adjusted incident rate ratio 1.98, 1.65-2.36), age (1.07, 1.05-1.09), female sex (0.61, 0.40-0.91), and current CD4 cell count (0.71, 0.59-0.85).
CONCLUSION: Among people aging with HIV in northern Italy, a frailty index based on deficit accumulation predicted survival and incident multimorbidity independently of HIV-related and behavioral risk factors. The frailty index holds potential value in quantifying vulnerability among people aging with HIV.

Entities:  

Mesh:

Year:  2015        PMID: 26372273     DOI: 10.1097/QAD.0000000000000753

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  51 in total

Review 1.  Geriatric syndromes: new frontiers in HIV and sarcopenia.

Authors:  Kellie L Hawkins; Todd T Brown; Joseph B Margolick; Kristine M Erlandson
Journal:  AIDS       Date:  2017-06-01       Impact factor: 4.177

2.  International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK.

Authors: 
Journal:  J Int AIDS Soc       Date:  2016-10-23       Impact factor: 5.396

3.  Integrating Frailty Research into the Medical Specialties-Report from a U13 Conference.

Authors:  Jeremy Walston; Thomas N Robinson; Susan Zieman; Frances McFarland; Christopher R Carpenter; Keri N Althoff; Melissa K Andrew; Caroline S Blaum; Patrick J Brown; Brian Buta; E Wesley Ely; Luigi Ferrucci; Kevin P High; Stephen B Kritchevsky; Kenneth Rockwood; Kenneth E Schmader; Felipe Sierra; Kaycee M Sink; Ravi Varadhan; Arti Hurria
Journal:  J Am Geriatr Soc       Date:  2017-04-19       Impact factor: 5.562

Review 4.  Assessment of geriatric syndromes and physical function in people living with HIV.

Authors:  Meredith Greene; Amy C Justice; Kenneth E Covinsky
Journal:  Virulence       Date:  2016-10-07       Impact factor: 5.882

5.  Association between Diet Quality and Frailty Prevalence in the Physicians' Health Study.

Authors:  Rachel E Ward; Ariela R Orkaby; Jiaying Chen; Tammy T Hshieh; Jane A Driver; J Michael Gaziano; Luc Djousse
Journal:  J Am Geriatr Soc       Date:  2019-12-16       Impact factor: 5.562

6.  Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus.

Authors:  Alexandra Legge; Susan Kirkland; Kenneth Rockwood; Pantelis Andreou; Sang-Cheol Bae; Caroline Gordon; Juanita Romero-Diaz; Jorge Sanchez-Guerrero; Daniel J Wallace; Sasha Bernatsky; Ann E Clarke; Joan T Merrill; Ellen M Ginzler; Paul Fortin; Dafna D Gladman; Murray B Urowitz; Ian N Bruce; David A Isenberg; Anisur Rahman; Graciela S Alarcón; Michelle Petri; Munther A Khamashta; M A Dooley; Rosalind Ramsey-Goldman; Susan Manzi; Kristjan Steinsson; Asad A Zoma; Cynthia Aranow; Meggan Mackay; Guillermo Ruiz-Irastorza; S Sam Lim; Murat Inanc; Ronald F van Vollenhoven; Andreas Jonsen; Ola Nived; Manuel Ramos-Casals; Diane L Kamen; Kenneth C Kalunian; Soren Jacobsen; Christine A Peschken; Anca Askanase; John G Hanly
Journal:  Arthritis Rheumatol       Date:  2019-05-29       Impact factor: 10.995

7.  Comorbidities in Older Persons with Controlled HIV Infection: Correlations with Frailty Index Subtypes.

Authors:  Jacqueline M McMillan; Michael John Gill; Christopher Power; Esther Fujiwara; David B Hogan; Leah H Rubin
Journal:  AIDS Patient Care STDS       Date:  2020-07       Impact factor: 5.078

8.  Frailty in Patients With Mild Autonomous Cortisol Secretion is Higher Than in Patients with Nonfunctioning Adrenal Tumors.

Authors:  Sumitabh Singh; Elizabeth J Atkinson; Sara J Achenbach; Nathan LeBrasseur; Irina Bancos
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

9.  Low thigh muscle mass is associated with coronary artery stenosis among HIV-infected and HIV-uninfected men: The Multicenter AIDS Cohort Study (MACS).

Authors:  Martin Tibuakuu; Di Zhao; Ankita Saxena; Todd T Brown; Lisa P Jacobson; Frank J Palella; Mallory D Witt; Susan L Koletar; Joseph B Margolick; Eliseo Guallar; Sai Krishna C Korada; Matthew J Budoff; Wendy S Post; Erin D Michos
Journal:  J Cardiovasc Comput Tomogr       Date:  2018-01-31

Review 10.  Ageing and inflammation in patients with HIV infection.

Authors:  M Nasi; S De Biasi; L Gibellini; E Bianchini; S Pecorini; V Bacca; G Guaraldi; C Mussini; M Pinti; A Cossarizza
Journal:  Clin Exp Immunol       Date:  2016-08-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.